Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 01, 2017
Source ID
10.1016/j.neurobiolaging.2017.08.010

Entities

People

  • Andrew D Simmons
  • Andrew J. Saykin
  • Clifford Jack
  • Emrin Horgusluoglu-moloch
  • John Q. Trojanowski
  • Kwangsik Nho
  • Leslie M. Shaw
  • Michael W. Weiner
  • Paul S. Aisen
  • Ronald C. Petersen
  • Shannon L. Risacher
  • Simon Lovestone
  • Sungeun Kim
  • Tatiana Foroud

Organizations

  • Alzheimer's Association
  • Alzheimer's Disease Neuroimaging Initiative
  • Alzheimer's Drug Discovery Foundation
  • BioClinica
  • Brin Wojcicki Foundation
  • Bristol-Myers Squibb
  • Canadian Institutes of Health Research
  • Chiron Corporation
  • Eisai
  • Eli Lilly and Company
  • GE HealthCare
  • Hoffmann-La Roche
  • Indiana Clinical and Translational Sciences Institute
  • Indiana University Health
  • Johnson & Johnson
  • Laboratoires Servier
  • Medpace
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • National Center for Advancing Translational Sciences
  • National Collegiate Athletic Association
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute of General Medical Sciences
  • National Institute on Aging
  • National Institutes of Health
  • National Science Foundation
  • Pfizer
  • Roche (United States)
  • Takeda Pharmaceutical Company
  • United States Department of Defense
  • United States National Library of Medicine